|
1.
|
World Health Organization: World Health
Organization Mortality Database. http://www-dep.iarc.fr/.
Accessed May 5, 2010.
|
|
2.
|
Yang L, Parkin DM, Ferlay J, Li L and Chen
Y: Estimates of cancer incidence in China for 2000 and projections
for 2005. Cancer Epidemiol Biomarkers Prev. 14:243–250.
2005.PubMed/NCBI
|
|
3.
|
Zhao P, Dai M, Chen W and Li N: Cancer
trends in China. Jpn J Clin Oncol. 40:281–285. 2010. View Article : Google Scholar
|
|
4.
|
Lichtenstein P, Holm NV, Verkasalo PK,
Iliadou A, Kaprio J, Koskenvuo M, et al: Environmental and
heritable factors in the causation of cancer - analyses of cohorts
of twins from Sweden, Denmark, and Finland. N Engl J Med.
343:78–85. 2000. View Article : Google Scholar
|
|
5.
|
Radtke F, Clevers H and Riccio O: From gut
homeostasis to cancer. Curr Mol Med. 6:275–289. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Tsong WH, Koh WP, Yuan JM, Wang R, Sun CL
and Yu MC: Cigarettes and alcohol in relation to colorectal cancer:
the Singapore Chinese Health Study. Br J Cancer. 96:821–827. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Moghaddam AA, Woodward M and Huxley R:
Obesity and risk of colorectal cancer: a meta-analysis of 31
studies with 70,000 events. Cancer Epidemiol Biomarkers Prev.
16:2533–2547. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Fang JY and Richardson BC: The MAPK
signalling pathways and colorectal cancer. Lancet Oncol. 6:322–327.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Wilson KP, Fitzgibbon MJ, Caron PR,
Griffith JP, Chen W, McCaffrey PG, et al: Crystal structure of p38
mitogen-activated protein kinase. J Biol Chem. 271:27696–27700.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Chiacchiera F and Simone C:
Signal-dependent regulation of gene expression as a target for
cancer treatment: inhibiting p38alpha in colorectal tumors. Cancer
Lett. 265:16–26. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Gout S, Morin C, Houle F and Huot J: Death
receptor-3, a new E-Selectin counter-receptor that confers
migration and survival advantages to colon carcinoma cells by
triggering p38 and ERK MAPK activation. Cancer Res. 66:9117–9124.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Wolf MJ, Hoos A, Bauer J, Boettcher S,
Knust M, Weber A, et al: Endothelial CCR2 signaling induced by
colon carcinoma cells enables extravasation via the JAK2-Stat5 and
p38MAPK pathway. Cancer Cell. 22:91–105. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Paillas S, Boissière F, Bibeau F, Denouel
A, Mollevi C, Causse A, et al: Targeting the p38 MAPK pathway
inhibits irinotecan resistance in colon adenocarcinoma. Cancer Res.
71:1041–1049. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Wei Y, Wang L, Lan P, Zhao H, Pan Z, Huang
J, et al: The association between -1304T>G polymorphism in the
promoter of MKK4 gene and the risk of sporadic colorectal cancer in
southern Chinese population. Int J Cancer. 125:1876–1883. 2009.
|
|
15.
|
Zhou BF; Cooperative Meta-Analysis Group
of the Working Group on Obesity in China: Predictive values of body
mass index and waist circumference for risk factors of certain
related diseases in Chinese adults - study on optimal cut-off
points of body mass index and waist circumference in Chinese
adults. Biomed Environ Sci. 15:83–96. 2002.PubMed/NCBI
|
|
16.
|
Reinhardt HC, Aslanian AS, Lees JA and
Yaffe MB: p53-deficient cells rely on ATM- and ATR-mediated
checkpoint signaling through the p38MAPK/MK2 pathway for survival
after DNA damage. Cancer Cell. 11:175–189. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Comes F, Matrone A, Lastella P, Nico B,
Susca FC, Bagnulo R, et al: A novel cell type-specific role of
p38alpha in the control of autophagy and cell death in colorectal
cancer cells. Cell Death Differ. 14:693–702. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Mechta F, Lallemand D, Pfarr CM and Yaniv
M: Transformation by ras modifies AP1 composition and activity.
Oncogene. 14:837–847. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Zhao M, New L, Kravchenko VV, Kato Y, Gram
H, di Padova F, et al: Regulation of the MEF2 family of
transcription factors by p38. Mol Cell Biol. 19:21–30.
1999.PubMed/NCBI
|
|
20.
|
Chen D, Song S, Lu J, Luo Y, Yang Z, Huang
Q, et al: Functional variants of -1318T > G and -673C > T in
c-Jun promoter region associated with increased colorectal cancer
risk by elevating promoter activity. Carcinogenesis. 32:1043–1049.
2011.
|
